{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:04:01Z","timestamp":1788537841684,"version":"build-2803163510"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009858","name":"Gabrielle\u2019s Angel Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009340","name":"Children\u2019s Discovery Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009340","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01988","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T09:34:48Z","timestamp":1597743288000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Immune Reconstitution in Pediatric Patients Following Hematopoietic Cell Transplant for Non-malignant Disorders"],"prefix":"10.3389","volume":"11","author":[{"given":"Sima T.","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Bednarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/1744666x.2019.1612746","article-title":"Immune reconstitution following hematopoietic stem cell transplantation using different stem cell sources.","volume":"15","author":"Elfeky","year":"2019","journal-title":"Expert Rev Clin Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/j.bbmt.2019.06.018","article-title":"Use of multivariate immune reconstitution patterns to describe immune reconstitution after allogeneic stem cell transplantation in children.","volume":"25","author":"Mellgren","year":"2019","journal-title":"Biol Blood Marrow Transplant."},{"key":"B3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4049\/jimmunol.1601100","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation: time to T up the thymus.","volume":"198","author":"Chaudhry","year":"2017","journal-title":"J Immunol."},{"key":"B4","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1182\/blood.V97.11.3380","article-title":"Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation.","volume":"97","author":"Storek","year":"2001","journal-title":"Blood."},{"key":"B5","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1365-2141.2010.08409.x","article-title":"Lymphocyte subset reconstitution after unrelated cord blood or bone marrow transplantation in children.","volume":"152","author":"Renard","year":"2011","journal-title":"Br J Haematol."},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00507","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation.","volume":"7","author":"Ogonek","year":"2016","journal-title":"Front Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/bmt.2012.176","article-title":"Reconstitution of maturating and regulatory lymphocyte subsets after cord blood and BMT in children.","volume":"48","author":"Charrier","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.bbmt.2017.05.005","article-title":"Humoral immune reconstitution kinetics after allogeneic hematopoietic stem cell transplantation in children: a maturation block of igm memory B cells may lead to impaired antibody immune reconstitution.","volume":"23","author":"Abdel-Azim","year":"2017","journal-title":"Biol Blood Marrow Transplant."},{"key":"B9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.bbmt.2012.10.010","article-title":"Immune reconstitution kinetics as an early predictor for mortality using various hematopoietic stem cell sources in children.","volume":"19","author":"Bartelink","year":"2013","journal-title":"Biol Blood Marrow Transplant."},{"key":"B10","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.jcyt.2015.03.614","article-title":"Immune reconstitution after cord blood transplantation: peculiarities, clinical implications and management strategies.","volume":"17","author":"Lucchini","year":"2015","journal-title":"Cytotherapy."},{"key":"B11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00068","article-title":"Improving engraftment and immune reconstitution in umbilical cord blood transplantation.","volume":"5","author":"Danby","year":"2014","journal-title":"Front Immunol."},{"key":"B12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bbmt.2015.09.013","article-title":"Infections after transplantation of bone marrow or peripheral blood stem cells from unrelated donors.","volume":"22","author":"Young","year":"2016","journal-title":"Biol Blood Marrow Transplant."},{"key":"B13","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1182\/blood-2014-03-563817","article-title":"HLA-haploidentical stem cell transplantation after removal of alphabeta+ T and B cells in children with nonmalignant disorders.","volume":"124","author":"Bertaina","year":"2014","journal-title":"Blood."},{"key":"B14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.bbmt.2016.11.014","article-title":"Early and long-term impaired T lymphocyte immune reconstitution after cord blood transplantation with antithymocyte globulin.","volume":"23","author":"Castillo","year":"2017","journal-title":"Biol Blood Marrow Transplant."},{"key":"B15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.stem.2015.10.004","article-title":"Phase I\/II Trial of StemRegenin-1 expanded umbilical cord blood hematopoietic stem cells supports testing as a stand-alone graft.","volume":"18","author":"Wagner","year":"2016","journal-title":"Cell Stem Cell."},{"key":"B16","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1399-3062.2011.00632.x","article-title":"Outcomes, infections, and immune reconstitution after double cord blood transplantation in patients with high-risk hematological diseases.","volume":"13","author":"Ruggeri","year":"2011","journal-title":"Transpl Infect Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.bbmt.2011.08.018","article-title":"Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation.","volume":"18","author":"Jacobson","year":"2012","journal-title":"Biol Blood Marrow Transplant."},{"key":"B18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1200\/jco.18.00053","article-title":"Phase I\/II study of stem-cell transplantation using a single cord blood unit expanded ex vivo with nicotinamide.","volume":"37","author":"Horwitz","year":"2019","journal-title":"J Clin Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/j.1365-2141.2011.08994.x","article-title":"Omission of in vivo T-cell depletion promotes rapid expansion of naive CD4+ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant.","volume":"156","author":"Chiesa","year":"2012","journal-title":"Br J Haematol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1016\/s2352-3026(15)00045-9","article-title":"Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis.","volume":"2","author":"Admiraal","year":"2015","journal-title":"Lancet Haematol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.bbmt.2016.03.009","article-title":"Cord blood units with high CD3(+) cell counts predict early lymphocyte recovery after in vivo T cell-depleted single cord blood transplantation.","volume":"22","author":"Castillo","year":"2016","journal-title":"Biol Blood Marrow Transplant."},{"key":"B22","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41409-019-0607-0","article-title":"Haploidentical hematopoietic stem cell transplantation with alphabetaTCR+\/CD19+ depletion in pediatric patients with malignant and non-malignant disorders.","volume":"54","author":"Bielorai","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"B23","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.bbmt.2013.11.028","article-title":"Immune reconstitution after haploidentical hematopoietic stem cell transplantation.","volume":"20","author":"Chang","year":"2014","journal-title":"Biol Blood Marrow Transplant."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.bbmt.2012.05.006","article-title":"Busulfan, fludarabine, and alemtuzumab as a reduced toxicity regimen for children with malignant and nonmalignant diseases improves engraftment and graft-versus-host disease without delaying immune reconstitution.","volume":"18","author":"Law","year":"2012","journal-title":"Biol Blood Marrow Transplant."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.bbmt.2015.04.009","article-title":"Experience with alemtuzumab, fludarabine, and melphalan reduced-intensity conditioning hematopoietic cell transplantation in patients with nonmalignant diseases reveals good outcomes and that the risk of mixed chimerism depends on underlying disease, stem cell source, and alemtuzumab regimen.","volume":"21","author":"Marsh","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"B26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.bbmt.2018.10.008","article-title":"Immune reconstitution and infection patterns after early alemtuzumab and reduced intensity transplantation for nonmalignant disorders in pediatric patients.","volume":"25","author":"Bhatt","year":"2019","journal-title":"Biol Blood Marrow Transplant."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1182\/blood.v96.7.2419.h8002419_2419_2425","article-title":"In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.","volume":"96","author":"Kottaridis","year":"2000","journal-title":"Blood."},{"key":"B28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/sj.bmt.1704795","article-title":"A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders.","volume":"35","author":"Shenoy","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.bbmt.2013.09.001","article-title":"An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis.","volume":"19","author":"Marsh","year":"2013","journal-title":"Biol Blood Marrow Transplant."},{"key":"B30","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1182\/blood-2015-07-659672","article-title":"Alemtuzumab levels impact acute GVHD, mixed chimerism, and lymphocyte recovery following alemtuzumab, fludarabine, and melphalan RIC HCT.","volume":"127","author":"Marsh","year":"2016","journal-title":"Blood."},{"key":"B31","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.bbmt.2009.01.016","article-title":"Cellular immune reconstitution and its impact on clinical outcome in children with beta thalassemia major undergoing a matched related myeloablative allogeneic bone marrow transplant.","volume":"15","author":"Rajasekar","year":"2009","journal-title":"Biol Blood Marrow Transplant."},{"key":"B32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/tid.12358","article-title":"Infectious complications following allogeneic stem cell transplantation by using anti-thymocyte globulin-based myeloablative conditioning regimens in children with hemoglobinopathies.","volume":"17","author":"Goussetis","year":"2015","journal-title":"Transpl Infect Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/ejh.13289","article-title":"Immune recovery after in vivo T-cell depletion myeloablative conditioning hematopoietic stem cell transplantation in severe beta-thalassemia children.","volume":"103","author":"Qin","year":"2019","journal-title":"Eur J Haematol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/ajh.24183","article-title":"Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies.","volume":"90","author":"King","year":"2015","journal-title":"Am J Hematol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1365-2141.2012.09066.x","article-title":"Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience.","volume":"157","author":"Samarasinghe","year":"2012","journal-title":"Br J Haematol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/pbc.25458","article-title":"Alemtuzumab based reduced intensity transplantation for pediatric severe aplastic anemia.","volume":"62","author":"Ngwube","year":"2015","journal-title":"Pediatr Blood Cancer."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/bmt.2017.174","article-title":"Immune reconstitution in patients with acquired severe aplastic anemia after haploidentical stem cell transplantation.","volume":"52","author":"Pei","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"B38","article-title":"Long term outcome and immune function after hematopoietic stem cell transplantation for primary immunodeficiency.","volume":"7","author":"Gennery","year":"2019","journal-title":"Front Pediatr."},{"key":"B39","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1586\/1744666x.2015.1041926","article-title":"Cytoreductive conditioning for severe combined immunodeficiency\u2013help or hindrance?","volume":"11","author":"Laberko","year":"2015","journal-title":"Expert Rev Clin Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/bmt.2017.74","article-title":"Unconditioned unrelated donor bone marrow transplantation for IL7R\u03b1- and Artemis-deficient SCID.","volume":"52","author":"Dvorak","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"B41","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2019.00295","article-title":"Hematopoietic stem cell transplantation in primary immunodeficiency diseases: current status and future perspectives.","volume":"7","author":"Castagnoli","year":"2019","journal-title":"Front Pediatr."},{"key":"B42","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000-2009.","volume":"371","author":"Pai","year":"2014","journal-title":"N Engl J Med."},{"key":"B43","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2011-12-396879","article-title":"Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency.","volume":"120","author":"Hassan","year":"2012","journal-title":"Blood."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1182\/blood-2017-05-781849","article-title":"Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.","volume":"130","author":"Heimall","year":"2017","journal-title":"Blood."},{"key":"B45","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1182\/blood-2018-03-840702","article-title":"SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.","volume":"132","author":"Haddad","year":"2018","journal-title":"Blood."},{"key":"B46","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nm1463","article-title":"Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation.","volume":"12","author":"Zakrzewski","year":"2006","journal-title":"Nat Med."},{"key":"B47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01854","article-title":"Adoptive T cell therapy following haploidentical hematopoietic stem cell transplantation.","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1182\/blood-2012-06-437236","article-title":"Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation.","volume":"120","author":"Perales","year":"2012","journal-title":"Blood."},{"key":"B49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.1218004","article-title":"Interleukin-22 drives endogenous thymic regeneration in mice.","volume":"336","author":"Dudakov","year":"2012","journal-title":"Science."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1158\/1078-0432.ccr-07-1784","article-title":"Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade.","volume":"14","author":"Sutherland","year":"2008","journal-title":"Clin Cancer Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbmt.2011.09.010","article-title":"Keratinocyte growth factor and stem cell factor to improve thymopoiesis after autologous CD34+ cell transplantation in rhesus macaques.","volume":"18","author":"Wils","year":"2012","journal-title":"Biol Blood Marrow Transplant."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01988\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T09:34:56Z","timestamp":1597743296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01988\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,18]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2020.01988"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01988","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,18]]},"article-number":"1988"}}